Corbus Pharmaceuticals Holdings Inc
F:3371
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Corbus Pharmaceuticals Holdings Inc
F:3371
|
US |
|
A
|
Abcellera Biologics Inc
F:8QQ
|
CA |
|
W
|
Wang On Group Ltd
XMUN:WON1
|
HK |
|
L
|
Lixil Corp
F:TJS
|
JP |
|
Blackline Inc
NASDAQ:BL
|
US |
|
T
|
Trinity Capital Inc
F:9F7
|
US |
|
360 DigiTech Inc
NASDAQ:QFIN
|
CN |
|
S
|
Sundial Growers Inc
F:14K
|
CA |
|
T
|
Takeda Pharmaceutical Co Ltd
XHAM:TKD
|
JP |
|
Zedge Inc
F:34Z
|
US |
|
T
|
Takeda Pharmaceutical Co Ltd
DUS:TKD
|
JP |
|
R
|
RadNet Inc
F:PQIA
|
US |
|
Kakaku.com Inc
F:KKC
|
JP |
|
Avon Protection PLC
F:1OK
|
UK |
|
Rexel SA
OTC:RXLSF
|
FR |
|
Amada Co Ltd
TSE:6113
|
JP |
|
Arca Continental SAB de CV
OTC:EMBVF
|
MX |
|
Pila Pharma AB
F:5KC
|
SE |
|
G
|
Guangdong Investment Ltd
F:GUG
|
HK |
|
Ameren Corp
NYSE:AEE
|
US |
|
Forvia SE
OTC:FAURY
|
FR |
|
F
|
Firstcash Holdings Inc
F:FF6
|
US |
|
B
|
Bukit Sembawang Estates Ltd
XMUN:B1W1
|
SG |
Bankruptcy Probability
Corbus Pharmaceuticals Holdings Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Corbus Pharmaceuticals Holdings Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Corbus Pharmaceuticals Holdings Inc
NASDAQ:CRBP
|
160.5m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
454.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
209.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
163B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
122.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
77.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
46.6B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Corbus Pharmaceuticals Holdings Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Corbus Pharmaceuticals Holdings Inc has no debt.
You can find a full breakdown on its Balance Sheet.
